Invention Grant
- Patent Title: Use of electrochemical impedance spectroscopy (EIS) in gross failure analysis
-
Application No.: US17115752Application Date: 2020-12-08
-
Publication No.: US11382527B2Publication Date: 2022-07-12
- Inventor: Andrea Varsavsky , Fei Yu , Ning Yang
- Applicant: MEDTRONIC MINIMED, INC.
- Applicant Address: US CA Northridge
- Assignee: MEDTRONIC MINIMED, INC.
- Current Assignee: MEDTRONIC MINIMED, INC.
- Current Assignee Address: US CA Northridge
- Agency: Carter, DeLuca & Farrell LLP
- Main IPC: A61B5/0537
- IPC: A61B5/0537 ; A61B5/145 ; A61B5/1468 ; A61B5/00 ; A61M5/158 ; A61B5/0538 ; A61B5/1473 ; A61B5/1495 ; A61B5/1486 ; G01N27/02 ; A61M5/172 ; A61M5/142
Abstract:
Electrochemical Impedance Spectroscopy (EIS) is used in conjunction with continuous glucose monitors and continuous glucose monitoring (CGM) to enable in-vivo sensor calibration, gross (sensor) failure analysis, and intelligent sensor diagnostics and fault detection. An equivalent circuit model is defined, and circuit elements are used to characterize sensor behavior.
Public/Granted literature
- US20210113111A1 USE OF ELECTROCHEMICAL IMPEDANCE SPECTROSCOPY (EIS) IN GROSS FAILURE ANALYSIS Public/Granted day:2021-04-22
Information query
IPC分类:
